Upgrade to SI Premium - Free Trial

Stoke Therapeutics (STOK) PT Lowered to $58 at Canaccord

August 4, 2026 6:44 AM
(Updated - August 4, 2026 6:57 AM EDT)

Canaccord analyst Sumant Kulkami lowered the price target on Stoke Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change